{
  "image_filename": "figure_p1_det_0_017.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p1_det_0_017.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_017",
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "supports_claim": false,
  "explanation": "Title page of an original article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age' with author names, no data or results shown does not support the claim because the image only shows the article title and authors without any data or findings on antibody responses for recombinant versus standard-dose vaccines",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Title page of an original article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age' with author names, no data or results shown",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image only shows the article title and authors without any data or findings on antibody responses for recombinant versus standard-dose vaccines",
    "confidence_notes": null
  }
}